Stabilization of superoxide dismutase by acetyl-l-carnitine in human brain endothelium during alcohol exposure: novel protective approach
Lancet 377:19291937 Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR (2011) Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication
However, discontinuation rates in Phase 2 were low (~6% at 12 mg), which suggests side effects were manageable for most participants
This is where formulation design becomes critical
Non-diabetic patients actually avoid hypoglycemia risks that diabetic users face, though they still require medical supervision for dose adjustment and side effect management